Peptic Ulcer Disease
📧 Sign up to get email alerts when something new happens for Peptic Ulcer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: Efficacy of Hemostasis by Soft Coagulation Using Endoscopic Hemostatic Forceps for Acute Peptic Ulcer Bleeding [NA]
A completed clinical trial evaluating the efficacy of soft coagulation using endoscopic hemostatic forceps for acute peptic ulcer bleeding.
-
FDA approval · 2015-12-16FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application to add PREVACID SOLUTAB (lansoprazole) as a soluble tablet formulation. This expands the approve…
-
FDA approval · 2015-10-30FDA Approved: SUCRALFATE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for sucralfate from Chartwell RX, LLC under an ANDA. The action represents an update to the approved…
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic Ulcers [Phase 4]
A Phase 4 trial assessed whether doubling the dose of oral esomeprazole reduces rebleeding in patients with bleeding peptic ulcers.
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: A Comparison of Two Therapeutic Strategies for the Treatment of Aspirin-associated Peptic Ulcers [Phase 4]
Phase 4 trial results compare two therapeutic strategies for treating aspirin-associated peptic ulcers. The study was conducted at Kaohsiung…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-09-03Clinical Trial Update: Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy [Phase 4]
Phase 4 trial comparing berberine quadruple therapy to a bismuth-containing quadruple therapy for Helicobacter pylori eradication in patient…
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Resistance of Helicobacter Pylori to Antibiotics in Children
A completed clinical trial (NCT01902589) investigated antibiotic resistance of Helicobacter pylori in pediatric patients, with results now a…
-
CLINICAL_TRIALS trial_result · 2015-08-31Clinical Trial Update: Rapid Urease Test for Diagnosis of H. Pylori Infection in Patients With Peptic Ulcer Bleeding [NA]
A completed clinical trial evaluating a rapid urease test for diagnosing Helicobacter pylori infection in patients with peptic ulcer disease…
-
FDA approval · 2015-08-27FDA Approved: SUCRALFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for sucralfate from Teva Pharmaceuticals USA, Inc., indicating approval of a change to an existi…
-
FDA approval · 2015-08-19FDA Approved: OMEPRAZOLE — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original application for a generic omeprazole product.
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Effect of IV and Oral Esomeprazole in Prevention of Recurrent Bleeding From Peptic Ulcers After Endoscopic Therapy [Phase 3]
A Phase 3 trial evaluated intravenous and oral esomeprazole to prevent recurrent bleeding after endoscopic therapy for peptic ulcers. The st…
-
FDA approval · 2015-08-03FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved an original application for Esomeprazole Magnesium from Mylan as a generic proton pump inhibitor. The approval makes a generic …
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery [NA]
Clinical trial update indicating completion of a study on postoperative oral nutritional supplementation after major gastrointestinal surger…
-
FDA approval · 2015-05-06FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Pepcid AC Maximum Strength (famotidine) submitted by Kenvue Brands LLC. This action expands the …
-
CLINICAL_TRIALS research · 2015-05-06Clinical Trial Update: WEI NASAL JET for The Sedation of Outpatient Upper Gastrointestinal Endoscopy [NA]
Clinical trial update on the WEI NASAL JET device for sedation during outpatient upper GI endoscopy; the trial status is unknown.
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Comparison of Conventional Triple Therapy Versus Sequential Therapy for H. Pylori in Peptic Ulcer Disease: Prospective Randomized Trial [Phase 4]
Phase 4 randomized trial comparing conventional triple therapy with sequential therapy for Helicobacter pylori in peptic ulcer disease.
-
CLINICAL_TRIALS trial_result · 2015-04-14Clinical Trial Update: Feasibility of Translumenal Endoscopic Omental Patch Closure of Perforated Viscus [NA]
A completed clinical trial evaluating the feasibility of translumenal endoscopic omental patch closure for perforated viscus in peptic ulcer…
-
FDA approval · 2015-03-06FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) submitted by AmerisourceBergen, under NDA 022032.
-
CLINICAL_TRIALS trial_result · 2015-02-03Clinical Trial Update: Amoxicillin/Metronidazole Based Quadruple Therapy for Helicobacter Pylori Eradication [Phase 4]
Phase 4 clinical trial update reporting completion of a study evaluating amoxicillin/metronidazole-based quadruple therapy for Helicobacter …
-
FDA approval · 2015-01-02FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for pantoprazole sodium filed by NorthStar Rx LLC.
-
FDA approval · 2014-12-19FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for omeprazole and sodium bicarbonate from Oceanside Pharmaceuticals, indicating an approved change …
-
FDA approval · 2014-12-19FDA Approved: ESOMEPRAZOLE STRONTIUM — Supplemental Application (R2 Pharma, LLC)
FDA approved a supplemental application for esomeprazole strontium from R2 Pharma, LLC, granting approval of this salt form under NDA 202342…
-
FDA approval · 2014-12-12FDA Approved: OMEPRAZOLE — Supplemental Application (Apotex Corp)
The FDA approved Apotex Corp's supplemental application for a generic omeprazole product.
-
FDA approval · 2014-12-05FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for pantoprazole sodium from Torrent Pharmaceuticals Limited, marking an update to the product's app…
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: HEP-FYN 12-Years Follow-up [NA]
This clinical trial update provides long-term follow-up data (12 years) from the HEP-FYN study, related to peptic ulcer disease, dyspepsia, …